100 related articles for article (PubMed ID: 7515629)
1. Correlation between ultrastructural and histochemical parameters in lymphokine-activated killer (LAK) cells reacting with target cells in vitro.
Nano R; Barni S; Capelli E; Cremaschi P; Catanese C; Tomaselli S; Nascimbene C; Prosperi E
Acta Oncol; 1994; 33(2):165-9. PubMed ID: 7515629
[TBL] [Abstract][Full Text] [Related]
2. DNA-protein cell content of lymphokine activated killer (LAK) and target cells in coculture.
Nano R; Barni S; Capelli E; Prosperi E; Lavezzi L; Salvucci O
Anticancer Res; 1995; 15(3):751-4. PubMed ID: 7645953
[TBL] [Abstract][Full Text] [Related]
3. Morphofunctional characterization of lymphokine activated killer (LAK) cells in vitro.
Nano R; Capelli E; Gerzeli G
Boll Soc Ital Biol Sper; 1995; 71(7-8):181-7. PubMed ID: 8519494
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lymphokine-activated killer cell induction by human recombinant IL-1 receptor antagonist. Obligate paracrine pathway of IL-1 during lymphokine-activated killer cell induction.
Fujiwara T; Grimm EA
J Immunol; 1992 May; 148(9):2941-6. PubMed ID: 1374105
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural characteristics of lymphokine-activated killer cells of the rat in comparison with natural killer cells.
Kaneda K; Nagamuta M; Kataoka M; Yamamoto H; Kishiye T; Wake K
Arch Histol Cytol; 1991 May; 54(2):119-32. PubMed ID: 1873071
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine-activated killer-cell-mediated killing of WiDr colon carcinoma cells is inhibited by K562 erythroleukemia cells.
Dullens HF; Wind JC; Maas RA; Bernsen MR; Vulto IM; Rademakers LH; Den Otter W
Int Immunol; 1991 Oct; 3(10):959-64. PubMed ID: 1756146
[TBL] [Abstract][Full Text] [Related]
7. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
Kimura K; Abe Y; Horiuchi A; Miyake M; Kimura S
Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
[TBL] [Abstract][Full Text] [Related]
8. Lysis of autologous human macrophages by lymphokine-activated killer cells: interaction of effector cell and target cell conjugates analyzed by scanning electron microscopy.
Streck RJ; Helinski EH; Ovak GM; Pauly JL
J Leukoc Biol; 1990 Sep; 48(3):237-46. PubMed ID: 2391448
[TBL] [Abstract][Full Text] [Related]
9. Morphologic analysis of human lymphokine-activated killer (LAK) cells.
Groscurth P; Diener S; Stahel R; Jost L; Kägi D; Hengartner H
Int J Cancer; 1990 Apr; 45(4):694-704. PubMed ID: 2157676
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor.
Teichmann JV; Ludwig WD; Thiel E
Leuk Res; 1992; 16(3):287-98. PubMed ID: 1560676
[TBL] [Abstract][Full Text] [Related]
11. Interactions of lymphokine-activated killer cells and A549 lung carcinoma nodules maintained in three-dimensional culture.
Gharib M; Tamboise E; Tamboise A; Lièvre N; Vérola O; Beaupain R
Tumour Biol; 1997; 18(3):135-45. PubMed ID: 9143410
[TBL] [Abstract][Full Text] [Related]
12. Interaction between lymphokine activated killer cells generated in the presence of cisplatin/FK-565 and tumor cells: transmission electron microscopy analysis.
Basu S; Sodhi A
Anticancer Drugs; 1992 Apr; 3(2):155-62. PubMed ID: 1525394
[TBL] [Abstract][Full Text] [Related]
13. Fibrin coating of bladder tumor cells (T24) is not protective against LAK cell cytotoxicity.
Carr ME; Sajer SA; Spaulding A
J Lab Clin Med; 1992 Feb; 119(2):132-8. PubMed ID: 1740625
[TBL] [Abstract][Full Text] [Related]
14. [Infiltrative and cytolytic activities of lymphokine-activated killer (LAK) cells against a human glioma mass: ultrastructural analysis using a three-dimensional multicellular spheroid model].
Iwasaki K
Nihon Geka Hokan; 1990 Jan; 59(1):39-54. PubMed ID: 2130768
[TBL] [Abstract][Full Text] [Related]
15. Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cells.
Misko IS; Schmidt C; Martin N; Moss DJ; Sculley TB; Burrows S; Burman KJ
Int J Cancer; 1990 Sep; 46(3):399-404. PubMed ID: 2168343
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.
Holladay FP; Heitz T; Wood GW
J Neurosurg; 1992 Nov; 77(5):757-62. PubMed ID: 1403119
[TBL] [Abstract][Full Text] [Related]
17. Substance P increases in vitro lymphokine-activated-killer (LAK) cell cytotoxicity against fresh colorectal cancer cells.
Flageole H; Senterman M; Trudel JL
J Surg Res; 1992 Nov; 53(5):445-9. PubMed ID: 1279274
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated killer cell activity after cryopreservation.
Schmidt-Wolf IG; Aihara M; Negrin RS; Blume KG; Chao NJ
J Immunol Methods; 1989 Dec; 125(1-2):185-9. PubMed ID: 2607152
[TBL] [Abstract][Full Text] [Related]
19. Lymphokine-activated killer activity in women with endometriosis.
Oosterlynck DJ; Lacquet FA; Waer M; Koninckx PR
Gynecol Obstet Invest; 1994; 37(3):185-90. PubMed ID: 8005550
[TBL] [Abstract][Full Text] [Related]
20. Intracellular calcium changes associated with in vitro lymphokine-activated killer and natural killer cell cytotoxicity.
Burkey BB; Omann GM; Wolf GT
Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1281-6. PubMed ID: 1747234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]